Post by
alleyesonme on Feb 16, 2022 6:12pm
Manipulation.
No material change within the company. It would appear big money is trying to keep shareprice down. The only motive would be to make their takeover bid more appealing...takeover attempt by year end financials?!?....sharks are circling medipharm has too much promise and ability to trade so low without someone taking a run at a buyout....official talks of a merger or buyout may be taking place as we speak...the board participated in a PP not long ago at .58c I think this could explain why they're not buying at 17c..that would be illegal if talks are underway....why so quite?? I was thinking new strategy but things just aren't adding up...I think the next news will be preceded by a trading halt...
Comment by
yureja on Feb 16, 2022 7:14pm
This post has been removed in accordance with Community Policy
Comment by
Conister011 on Feb 18, 2022 8:51am
Interesting points, your probably on to something. Clean balance sheet and a unique product and facility as well as international footprint. Would be a nice addition to larger cos. GLTA
Comment by
alleyesonme on Feb 18, 2022 4:01pm
Global demand is estimated to grow 28% annually to 2025 by Forbes...the pie is growing substantially...this time next year the conversation will be much different and so will the sentiment.